Development Of Antibody Immobilisation Strategy Using Recombinant Human Neonatal Fc Receptor

Antibody immobilisation is the cornerstone of antibody-based assay in biosensing technology which is predominantly used to detect and measure a wide variety of biological analytes, ranging from antigens, biomarkers, allergens and drug substances. As such, specific interactions between antibody and l...

Description complète

Détails bibliographiques
Auteur principal: Ng,, Woei Kean
Format: Thèse
Langue:anglais
Publié: 2017
Sujets:
Accès en ligne:http://eprints.usm.my/45441/
_version_ 1846216893291036672
author Ng,, Woei Kean
author_facet Ng,, Woei Kean
author_sort Ng,, Woei Kean
description Antibody immobilisation is the cornerstone of antibody-based assay in biosensing technology which is predominantly used to detect and measure a wide variety of biological analytes, ranging from antigens, biomarkers, allergens and drug substances. As such, specific interactions between antibody and ligands are therefore needed to guarantee highest reproducibility and sensitivity possible. The complexity of pinning antibodies forms the key factor in interfering the outcome of an assay as the recognition molecule, i.e. the antibody itself, may have undergone structural changes and distortion when it is attached to the solid phase.
first_indexed 2025-10-17T08:27:13Z
format Thesis
id usm-45441
institution Universiti Sains Malaysia
language English
last_indexed 2025-10-17T08:27:13Z
publishDate 2017
record_format eprints
spelling usm-454412019-09-17T06:44:13Z http://eprints.usm.my/45441/ Development Of Antibody Immobilisation Strategy Using Recombinant Human Neonatal Fc Receptor Ng,, Woei Kean R735-854 Medical education. Medical schools. Research Antibody immobilisation is the cornerstone of antibody-based assay in biosensing technology which is predominantly used to detect and measure a wide variety of biological analytes, ranging from antigens, biomarkers, allergens and drug substances. As such, specific interactions between antibody and ligands are therefore needed to guarantee highest reproducibility and sensitivity possible. The complexity of pinning antibodies forms the key factor in interfering the outcome of an assay as the recognition molecule, i.e. the antibody itself, may have undergone structural changes and distortion when it is attached to the solid phase. 2017-08 Thesis NonPeerReviewed application/pdf en http://eprints.usm.my/45441/1/NG%20WOEI%20KEAN.pdf Ng,, Woei Kean (2017) Development Of Antibody Immobilisation Strategy Using Recombinant Human Neonatal Fc Receptor. PhD thesis, Universiti Sains Malaysia.
spellingShingle R735-854 Medical education. Medical schools. Research
Ng,, Woei Kean
Development Of Antibody Immobilisation Strategy Using Recombinant Human Neonatal Fc Receptor
title Development Of Antibody Immobilisation Strategy Using Recombinant Human Neonatal Fc Receptor
title_full Development Of Antibody Immobilisation Strategy Using Recombinant Human Neonatal Fc Receptor
title_fullStr Development Of Antibody Immobilisation Strategy Using Recombinant Human Neonatal Fc Receptor
title_full_unstemmed Development Of Antibody Immobilisation Strategy Using Recombinant Human Neonatal Fc Receptor
title_short Development Of Antibody Immobilisation Strategy Using Recombinant Human Neonatal Fc Receptor
title_sort development of antibody immobilisation strategy using recombinant human neonatal fc receptor
topic R735-854 Medical education. Medical schools. Research
url http://eprints.usm.my/45441/
work_keys_str_mv AT ngwoeikean developmentofantibodyimmobilisationstrategyusingrecombinanthumanneonatalfcreceptor